FreeStyle Navigator Trial To Delay Abbott’s CGMS Debut
This article was originally published in The Gray Sheet
Executive Summary
Abbott/TheraSense has pushed back its planned launch of the Freestyle Navigator continuous blood glucose monitor until the second half of 2005
You may also be interested in...
Continuous Glucose Monitor Market Remains In Abbott’s Sights
Abbott says an FDA inspection of one third-party supplier is the only remaining barrier to PMA approval for its long-delayed Freestyle Navigator continuous glucose monitor
Continuous Glucose Monitor Market Remains In Abbott’s Sights
Abbott says an FDA inspection of one third-party supplier is the only remaining barrier to PMA approval for its long-delayed Freestyle Navigator continuous glucose monitor
Diabetes Market May Top $1 Bil. With Stick Replacement Claim – Abbott
Abbott Labs expects its Freestyle Navigator to be the first continuous blood glucose monitor approved in the U.S. as a replacement for traditional fingerstick tests